{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:42:37Z","timestamp":1790206957722,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hereditary transthyretin (TTR) amyloidosis (hATTR) is a rare life-threatening disorder caused by amyloidogenic coding mutations located in\n                    <jats:italic>TTR<\/jats:italic>\n                    gene. To understand the high phenotypic variability observed among carriers of\n                    <jats:italic>TTR<\/jats:italic>\n                    disease-causing mutations, we conducted an epigenome-wide association study (EWAS) assessing more than 700,000 methylation sites and testing epigenetic difference of\n                    <jats:italic>TTR<\/jats:italic>\n                    coding mutation carriers\n                    <jats:italic>vs<\/jats:italic>\n                    . non-carriers. We observed a significant methylation change at cg09097335 site located in\n                    <jats:italic>Beta-secretase 2<\/jats:italic>\n                    (\n                    <jats:italic>BACE2<\/jats:italic>\n                    ) gene (standardized regression coefficient\u2009=\u2009\u22120.60,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20096.26\u2009\u00d7\u200910\n                    <jats:sup>\u20138<\/jats:sup>\n                    ). This gene is involved in a protein interaction network enriched for biological processes and molecular pathways related to amyloid-beta metabolism (Gene Ontology: 0050435,\n                    <jats:italic>q<\/jats:italic>\n                    \u2009=\u20090.007), amyloid fiber formation (Reactome HSA-977225,\n                    <jats:italic>q<\/jats:italic>\n                    \u2009=\u20090.008), and Alzheimer\u2019s disease (KEGG hsa05010,\n                    <jats:italic>q<\/jats:italic>\n                    \u2009=\u20092.2\u2009\u00d7\u200910\n                    <jats:sup>\u20134<\/jats:sup>\n                    ). Additionally,\n                    <jats:italic>TTR<\/jats:italic>\n                    and\n                    <jats:italic>BACE2<\/jats:italic>\n                    share APP (amyloid-beta precursor protein) as a validated protein interactor. Within\n                    <jats:italic>TTR<\/jats:italic>\n                    gene region, we observed that Val30Met disrupts a methylation site, cg13139646, causing a drastic hypomethylation in carriers of this amyloidogenic mutation (standardized regression coefficient\u2009=\u2009\u22122.18,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20093.34\u2009\u00d7\u200910\n                    <jats:sup>\u201311<\/jats:sup>\n                    ). Cg13139646 showed co-methylation with cg19203115 (Pearson\u2019s\n                    <jats:italic>r<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u20090.32), which showed significant epigenetic differences between symptomatic and asymptomatic carriers of amyloidogenic mutations (standardized regression coefficient\u2009=\u2009\u22120.56,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20098.6\u2009\u00d7\u200910\n                    <jats:sup>\u20134<\/jats:sup>\n                    ). In conclusion, we provide novel insights related to the molecular mechanisms involved in the complex heterogeneity of hATTR, highlighting the role of epigenetic regulation in this rare disorder.\n                  <\/jats:p>","DOI":"10.1186\/s13148-020-00967-6","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T13:02:58Z","timestamp":1605618178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Epigenetic profiling of Italian patients identified methylation sites associated with hereditary transthyretin amyloidosis"],"prefix":"10.1186","volume":"12","author":[{"given":"Antonella","family":"De Lillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gita A.","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Di Girolamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Luigetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Sabatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Perfetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Frusconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Manfellotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fuciarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0745-6046","authenticated-orcid":false,"given":"Renato","family":"Polimanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"issue":"15","key":"967_CR1","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.2174\/092986712800269335","volume":"19","author":"SK Palaninathan","year":"2012","unstructured":"Palaninathan SK. Nearly 200 X-ray crystal structures of transthyretin: what do they tell us about this protein and the design of drugs for TTR amyloidoses? Curr Med Chem. 2012;19(15):2324\u201342.","journal-title":"Curr Med Chem"},{"key":"967_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2047-9158-3-19","volume":"3","author":"M Ueda","year":"2014","unstructured":"Ueda M, Ando Y. Recent advances in transthyretin amyloidosis therapy. Transl Neurodegener. 2014;3:19.","journal-title":"Transl Neurodegener"},{"issue":"3","key":"967_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/13506120802193720","volume":"15","author":"U Hellman","year":"2008","unstructured":"Hellman U, Alarcon F, Lundgren HE, Suhr OB, Bonaiti-Pellie C, Plante-Bordeneuve V. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population. Amyloid. 2008;15(3):181\u20136.","journal-title":"Amyloid"},{"issue":"Suppl 1","key":"967_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3109\/13506129.2012.673184","volume":"19","author":"I Conceicao","year":"2012","unstructured":"Conceicao I. Clinical features of TTR-FAP in Portugal. Amyloid. 2012;19(Suppl 1):71\u20132.","journal-title":"Amyloid"},{"issue":"Suppl 1","key":"967_CR5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/WCO.0000000000000288","volume":"29","author":"Y Parman","year":"2016","unstructured":"Parman Y, Adams D, Obici L, Galan L, Guergueltcheva V, Suhr OB, et al. Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP. Curr Opin Neurol. 2016;29(Suppl 1):S3\u201313.","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"967_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/13506129.2018.1556156","volume":"26","author":"I Conceicao","year":"2019","unstructured":"Conceicao I, Damy T, Romero M, Galan L, Attarian S, Luigetti M, et al. Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations. Amyloid. 2019;26(1):3\u20139.","journal-title":"Amyloid"},{"key":"967_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-8-31","volume":"8","author":"Y Ando","year":"2013","unstructured":"Ando Y, Coelho T, Berk JL, Cruz MW, Ericzon BG, Ikeda S, et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. 2013;8:31.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"967_CR8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ajmg.1320600606","volume":"60","author":"A Sousa","year":"1995","unstructured":"Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet. 1995;60(6):512\u201321.","journal-title":"Am J Med Genet"},{"issue":"11","key":"967_CR9","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1136\/jmg.40.11.e120","volume":"40","author":"V Plante-Bordeneuve","year":"2003","unstructured":"Plante-Bordeneuve V, Carayol J, Ferreira A, Adams D, Clerget-Darpoux F, Misrahi M, et al. Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese families. J Med Genet. 2003;40(11):e120.","journal-title":"J Med Genet"},{"issue":"5","key":"967_CR10","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1159\/000154146","volume":"43","author":"A Sousa","year":"1993","unstructured":"Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered. 1993;43(5):288\u201394.","journal-title":"Hum Hered"},{"issue":"7","key":"967_CR11","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s10072-012-1105-y","volume":"34","author":"M Luigetti","year":"2013","unstructured":"Luigetti M, Conte A, Del Grande A, Bisogni G, Madia F, Lo Monaco M, et al. TTR-related amyloid neuropathy: clinical, electrophysiological and pathological findings in 15 unrelated patients. Neurol Sci. 2013;34(7):1057\u201363.","journal-title":"Neurol Sci"},{"issue":"5","key":"967_CR12","first-page":"3676","volume":"55","author":"M Alves-Ferreira","year":"2018","unstructured":"Alves-Ferreira M, Coelho T, Santos D, Sequeiros J, Alonso I, Sousa A, et al. A Trans-acting factor may modify age at onset in familial amyloid polyneuropathy ATTRV30M in Portugal. Mol Neurobiol. 2018;55(5):3676\u201383.","journal-title":"Mol Neurobiol"},{"issue":"8","key":"967_CR13","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/ejhg.2010.36","volume":"18","author":"B Bonaiti","year":"2010","unstructured":"Bonaiti B, Olsson M, Hellman U, Suhr O, Bonaiti-Pellie C, Plante-Bordeneuve V. TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance? Eur J Hum Genet. 2010;18(8):948\u201352.","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"967_CR14","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/ejhg.2015.180","volume":"24","author":"D Santos","year":"2016","unstructured":"Santos D, Coelho T, Alves-Ferreira M, Sequeiros J, Mendonca D, Alonso I, et al. Variants in RBP4 and AR genes modulate age at onset in familial amyloid polyneuropathy (FAP ATTRV30M). Eur J Hum Genet. 2016;24(5):756\u201360.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"967_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/hmg\/ddi051","volume":"14","author":"ML Soares","year":"2005","unstructured":"Soares ML, Coelho T, Sousa A, Batalov S, Conceicao I, Sales-Luis ML, et al. Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease. Hum Mol Genet. 2005;14(4):543\u201353.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"967_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3109\/13506129.2014.994597","volume":"22","author":"A Iorio","year":"2015","unstructured":"Iorio A, De Angelis F, Di Girolamo M, Luigetti M, Pradotto L, Mauro A, et al. Most recent common ancestor of TTR Val30Met mutation in Italian population and its potential role in genotype-phenotype correlation. Amyloid. 2015;22(2):73\u20138.","journal-title":"Amyloid"},{"issue":"4","key":"967_CR17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3109\/13506129.2013.844689","volume":"20","author":"R Polimanti","year":"2013","unstructured":"Polimanti R, Di Girolamo M, Manfellotto D, Fuciarelli M. Functional variation of the transthyretin gene among human populations and its correlation with amyloidosis phenotypes. Amyloid. 2013;20(4):256\u201362.","journal-title":"Amyloid"},{"issue":"3","key":"967_CR18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3109\/13506129.2014.900487","volume":"21","author":"R Polimanti","year":"2014","unstructured":"Polimanti R, Di Girolamo M, Manfellotto D, Fuciarelli M. In silico analysis of TTR gene (coding and non-coding regions, and interactive network) and its implications in transthyretin-related amyloidosis. Amyloid. 2014;21(3):154\u201362.","journal-title":"Amyloid"},{"issue":"1","key":"967_CR19","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12864-017-3646-1","volume":"18","author":"A Iorio","year":"2017","unstructured":"Iorio A, De Angelis F, Di Girolamo M, Luigetti M, Pradotto LG, Mazzeo A, et al. Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis. BMC Genomics. 2017;18(1):254.","journal-title":"BMC Genomics"},{"issue":"9","key":"967_CR20","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ejhg.2017.95","volume":"25","author":"A Iorio","year":"2017","unstructured":"Iorio A, De Lillo A, De Angelis F, Di Girolamo M, Luigetti M, Sabatelli M, et al. Non-coding variants contribute to the clinical heterogeneity of TTR amyloidosis. Eur J Hum Genet. 2017;25(9):1055\u201360.","journal-title":"Eur J Hum Genet"},{"issue":"11\u201312","key":"967_CR21","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00439-019-02078-6","volume":"138","author":"A De Lillo","year":"2019","unstructured":"De Lillo A, De Angelis F, Di Girolamo M, Luigetti M, Frusconi S, Manfellotto D, et al. Phenome-wide association study of TTR and RBP4 genes in 361,194 individuals reveals novel insights in the genetics of hereditary and wildtype transthyretin amyloidoses. Hum Genet. 2019;138(11\u201312):1331\u201340.","journal-title":"Hum Genet"},{"key":"967_CR22","doi-asserted-by":"crossref","unstructured":"Polimanti R, Nunez YZ, Gelernter J. Increased risk of multiple outpatient surgeries in African-American Carriers of Transthyretin Val122Ile mutation is modulated by non-coding variants. J Clin Med. 2019;8(2).","DOI":"10.3390\/jcm8020269"},{"issue":"14","key":"967_CR23","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1056\/NEJMra1402513","volume":"378","author":"AP Feinberg","year":"2018","unstructured":"Feinberg AP. The key role of epigenetics in human disease prevention and mitigation. N Engl J Med. 2018;378(14):1323\u201334.","journal-title":"N Engl J Med"},{"issue":"2","key":"967_CR24","first-page":"96","volume":"183","author":"H Yan","year":"2016","unstructured":"Yan H, Tian S, Slager SL, Sun Z, Ordog T. Genome-wide epigenetic studies in human disease: a primer on-omic technologies. Am J Epidemiol. 2016;183(2):96\u2013109.","journal-title":"Am J Epidemiol"},{"key":"967_CR25","doi-asserted-by":"crossref","unstructured":"Szymczak S, Dose J, Torres GG, Heinsen FA, Venkatesh G, Datlinger P, et al. DNA methylation QTL analysis identifies new regulators of human longevity. Hum Mol Genet. 2020.","DOI":"10.1093\/hmg\/ddaa033"},{"issue":"1","key":"967_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13148-018-0530-z","volume":"10","author":"RL Clissold","year":"2018","unstructured":"Clissold RL, Ashfield B, Burrage J, Hannon E, Bingham C, Mill J, et al. Genome-wide methylomic analysis in individuals with HNF1B intragenic mutation and 17q12 microdeletion. Clin Epigenet. 2018;10(1):97.","journal-title":"Clin Epigenet"},{"issue":"5","key":"967_CR27","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4161\/epi.19633","volume":"7","author":"SP Guay","year":"2012","unstructured":"Guay SP, Brisson D, Munger J, Lamarche B, Gaudet D, Bouchard L. ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia. Epigenetics. 2012;7(5):464\u201372.","journal-title":"Epigenetics"},{"key":"967_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13148-016-0300-8","volume":"9","author":"M Magalhaes","year":"2017","unstructured":"Magalhaes M, Rivals I, Claustres M, Varilh J, Thomasset M, Bergougnoux A, et al. DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis. Clin Epigenet. 2017;9:19.","journal-title":"Clin Epigenet"},{"key":"967_CR29","unstructured":"Aguet F, Barbeira AN, Bonazzola R, Brown A, Castel SE, Jo B, et al. The GTEx Consortium atlas of genetic regulatory effects across human tissues. bioRxiv. 2019:787903."},{"key":"967_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/TCRM.S219979","volume":"16","author":"M Luigetti","year":"2020","unstructured":"Luigetti M, Romano A, Di Paolantonio A, Bisogni G, Sabatelli M. Diagnosis and treatment of hereditary transthyretin amyloidosis (hATTR) polyneuropathy: current perspectives on improving patient care. Ther Clin Risk Manag. 2020;16:109\u201323.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"967_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1750-1326-6-27","volume":"6","author":"H Zheng","year":"2011","unstructured":"Zheng H, Koo EH. Biology and pathophysiology of the amyloid precursor protein. Mol Neurodegener. 2011;6(1):27.","journal-title":"Mol Neurodegener"},{"issue":"6","key":"967_CR32","doi-asserted-by":"publisher","first-page":"e0150079","DOI":"10.1371\/journal.pone.0150079","volume":"11","author":"C Sassi","year":"2016","unstructured":"Sassi C, Ridge PG, Nalls MA, Gibbs R, Ding J, Lupton MK, et al. Influence of coding variability in APP-abeta metabolism genes in sporadic Alzheimer\u2019s disease. PLoS ONE. 2016;11(6):e0150079.","journal-title":"PLoS ONE"},{"key":"967_CR33","doi-asserted-by":"crossref","unstructured":"Wang Z, Xu Q, Cai F, Liu X, Wu Y, Song W. BACE2, a conditional beta-secretase, contributes to Alzheimer's disease pathogenesis. JCI Insight. 2019;4(1).","DOI":"10.1172\/jci.insight.123431"},{"issue":"1","key":"967_CR34","doi-asserted-by":"publisher","first-page":"e201800026","DOI":"10.26508\/lsa.201800026","volume":"1","author":"I Voytyuk","year":"2018","unstructured":"Voytyuk I, Mueller SA, Herber J, Snellinx A, Moechars D, van Loo G, et al. BACE2 distribution in major brain cell types and identification of novel substrates. Life Sci Alliance. 2018;1(1):e201800026.","journal-title":"Life Sci Alliance"},{"key":"967_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1756-6606-4-3","volume":"4","author":"YW Zhang","year":"2011","unstructured":"Zhang YW, Thompson R, Zhang H, Xu H. APP processing in Alzheimer\u2019s disease. Mol Brain. 2011;4:3.","journal-title":"Mol Brain"},{"issue":"3","key":"967_CR36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41380-018-0091-8","volume":"25","author":"D Hartl","year":"2020","unstructured":"Hartl D, May P, Gu W, Mayhaus M, Pichler S, Spaniol C, et al. A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease. Mol Psychiatry. 2020;25(3):629\u201339.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"967_CR37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.neuron.2013.08.035","volume":"80","author":"J Suh","year":"2013","unstructured":"Suh J, Choi SH, Romano DM, Gannon MA, Lesinski AN, Kim DY, et al. ADAM10 missense mutations potentiate beta-amyloid accumulation by impairing prodomain chaperone function. Neuron. 2013;80(2):385\u2013401.","journal-title":"Neuron"},{"key":"967_CR38","doi-asserted-by":"crossref","unstructured":"Tambini MD, Norris KA, D'Adamio L. Opposite changes in APP processing and human Abeta levels in rats carrying either a protective or a pathogenic APP mutation. Elife. 2020;9.","DOI":"10.7554\/eLife.52612"},{"issue":"2","key":"967_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41419-020-2288-4","volume":"11","author":"CS Durrant","year":"2020","unstructured":"Durrant CS, Ruscher K, Sheppard O, Coleman MP, Ozen I. Beta secretase 1-dependent amyloid precursor protein processing promotes excessive vascular sprouting through NOTCH3 signalling. Cell Death Dis. 2020;11(2):98.","journal-title":"Cell Death Dis"},{"issue":"7","key":"967_CR40","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/cns.12707","volume":"23","author":"M Alemi","year":"2017","unstructured":"Alemi M, Silva SC, Santana I, Cardoso I. Transthyretin stability is critical in assisting beta amyloid clearance: relevance of transthyretin stabilization in Alzheimer\u2019s disease. CNS Neurosci Ther. 2017;23(7):605\u201319.","journal-title":"CNS Neurosci Ther"},{"issue":"6","key":"967_CR41","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.febslet.2008.02.034","volume":"582","author":"R Costa","year":"2008","unstructured":"Costa R, Goncalves A, Saraiva MJ, Cardoso I. Transthyretin binding to A-Beta peptide\u2013impact on A-Beta fibrillogenesis and toxicity. FEBS Lett. 2008;582(6):936\u201342.","journal-title":"FEBS Lett"},{"issue":"38","key":"967_CR42","doi-asserted-by":"publisher","first-page":"8276","DOI":"10.1021\/bi101280t","volume":"49","author":"J Du","year":"2010","unstructured":"Du J, Murphy RM. Characterization of the interaction of beta-amyloid with transthyretin monomers and tetramers. Biochemistry. 2010;49(38):8276\u201389.","journal-title":"Biochemistry"},{"key":"967_CR43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jns.2017.08.3240","volume":"381","author":"K Sakai","year":"2017","unstructured":"Sakai K, Asakawa M, Takahashi R, Ishida C, Nakamura R, Hamaguchi T, et al. Coexistence of transthyretin- and Abeta-type cerebral amyloid angiopathy in a patient with hereditary transthyretin V30M amyloidosis. J Neurol Sci. 2017;381:144\u20136.","journal-title":"J Neurol Sci"},{"issue":"7","key":"967_CR44","doi-asserted-by":"publisher","first-page":"5192","DOI":"10.1007\/s12035-016-0065-2","volume":"54","author":"Q Xiang","year":"2017","unstructured":"Xiang Q, Bi R, Xu M, Zhang DF, Tan L, Zhang C, et al. Rare genetic variants of the transthyretin gene are associated with Alzheimer\u2019s disease in Han Chinese. Mol Neurobiol. 2017;54(7):5192\u2013200.","journal-title":"Mol Neurobiol"},{"issue":"26","key":"967_CR45","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.1523\/JNEUROSCI.1919-07.2007","volume":"27","author":"SH Choi","year":"2007","unstructured":"Choi SH, Leight SN, Lee VM, Li T, Wong PC, Johnson JA, et al. Accelerated Abeta deposition in APPswe\/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin). J Neurosci. 2007;27(26):7006\u201310.","journal-title":"J Neurosci"},{"issue":"3","key":"967_CR46","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/jnc.12680","volume":"130","author":"C Kerridge","year":"2014","unstructured":"Kerridge C, Belyaev ND, Nalivaeva NN, Turner AJ. The Abeta-clearance protein transthyretin, like neprilysin, is epigenetically regulated by the amyloid precursor protein intracellular domain. J Neurochem. 2014;130(3):419\u201331.","journal-title":"J Neurochem"},{"issue":"1","key":"967_CR47","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12883-019-1369-4","volume":"19","author":"EP Azevedo","year":"2019","unstructured":"Azevedo EP, Guimaraes-Costa AB, Bandeira-Melo C, Chimelli L, Waddington-Cruz M, Saraiva EM, et al. Inflammatory profiling of patients with familial amyloid polyneuropathy. BMC Neurol. 2019;19(1):146.","journal-title":"BMC Neurol"},{"issue":"8","key":"967_CR48","doi-asserted-by":"publisher","first-page":"e1002228","DOI":"10.1371\/journal.pgen.1002228","volume":"7","author":"J Gertz","year":"2011","unstructured":"Gertz J, Varley KE, Reddy TE, Bowling KM, Pauli F, Parker SL, et al. Analysis of DNA methylation in a three-generation family reveals widespread genetic influence on epigenetic regulation. PLoS Genet. 2011;7(8):e1002228.","journal-title":"PLoS Genet"},{"issue":"1","key":"967_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1756-8935-3-11","volume":"3","author":"A Hellman","year":"2010","unstructured":"Hellman A, Chess A. Extensive sequence-influenced DNA methylation polymorphism in the human genome. Epigenet Chromatin. 2010;3(1):11.","journal-title":"Epigenet Chromatin"},{"issue":"1","key":"967_CR50","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ygeno.2019.05.007","volume":"112","author":"O Affinito","year":"2020","unstructured":"Affinito O, Palumbo D, Fierro A, Cuomo M, De Riso G, Monticelli A, et al. Nucleotide distance influences co-methylation between nearby CpG sites. Genomics. 2020;112(1):144\u201350.","journal-title":"Genomics"},{"issue":"10","key":"967_CR51","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.3681","volume":"20","author":"L Mayo","year":"2014","unstructured":"Mayo L, Trauger SA, Blain M, Nadeau M, Patel B, Alvarez JI, et al. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat Med. 2014;20(10):1147\u201356.","journal-title":"Nat Med"},{"issue":"5","key":"967_CR52","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.joa.2016.01.006","volume":"32","author":"S Ohno","year":"2016","unstructured":"Ohno S. The genetic background of arrhythmogenic right ventricular cardiomyopathy. J Arrhythm. 2016;32(5):398\u2013403.","journal-title":"J Arrhythm"},{"issue":"3","key":"967_CR53","doi-asserted-by":"publisher","first-page":"e0174019","DOI":"10.1371\/journal.pone.0174019","volume":"12","author":"A Brodehl","year":"2017","unstructured":"Brodehl A, Belke DD, Garnett L, Martens K, Abdelfatah N, Rodriguez M, et al. Transgenic mice overexpressing desmocollin-2 (DSC2) develop cardiomyopathy associated with myocardial inflammation and fibrotic remodeling. PLoS ONE. 2017;12(3):e0174019.","journal-title":"PLoS ONE"},{"issue":"3","key":"967_CR54","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.cjca.2019.11.039","volume":"36","author":"CC Cheung","year":"2020","unstructured":"Cheung CC, Roston TM, Andrade JG, Bennett MT, Davis MK. Arrhythmias in cardiac amyloidosis: challenges in risk stratification and treatment. Can J Cardiol. 2020;36(3):416\u201323.","journal-title":"Can J Cardiol"},{"issue":"5","key":"967_CR55","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11864-020-00738-8","volume":"21","author":"AVS Macedo","year":"2020","unstructured":"Macedo AVS, Schwartzmann PV, de Gusmao BM, Melo MDT, Coelho-Filho OR. Advances in the treatment of cardiac amyloidosis. Curr Treat Options Oncol. 2020;21(5):36.","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"967_CR56","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/13506129.2018.1430027","volume":"25","author":"MY Henein","year":"2018","unstructured":"Henein MY, Suhr OB, Arvidsson S, Pilebro B, Westermark P, Hornsten R, et al. Reduced left atrial myocardial deformation irrespective of cavity size: a potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis. Amyloid. 2018;25(1):46\u201353.","journal-title":"Amyloid"},{"issue":"9","key":"967_CR57","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1152\/physiolgenomics.00143.2017","volume":"50","author":"PR Prestes","year":"2018","unstructured":"Prestes PR, Marques FZ, Lopez-Campos G, Lewandowski P, Delbridge LMD, Charchar FJ, et al. Involvement of human monogenic cardiomyopathy genes in experimental polygenic cardiac hypertrophy. Physiol Genomics. 2018;50(9):680\u20137.","journal-title":"Physiol Genomics"},{"issue":"4","key":"967_CR58","doi-asserted-by":"publisher","first-page":"462","DOI":"10.18632\/oncotarget.497","volume":"3","author":"D Jjingo","year":"2012","unstructured":"Jjingo D, Conley AB, Yi SV, Lunyak VV, Jordan IK. On the presence and role of human gene-body DNA methylation. Oncotarget. 2012;3(4):462\u201374.","journal-title":"Oncotarget"},{"issue":"5","key":"967_CR59","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7150\/ijbs.11218","volume":"11","author":"H Meng","year":"2015","unstructured":"Meng H, Cao Y, Qin J, Song X, Zhang Q, Shi Y, et al. DNA methylation, its mediators and genome integrity. Int J Biol Sci. 2015;11(5):604\u201317.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"967_CR60","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ajhg.2009.08.015","volume":"85","author":"M Ayub","year":"2009","unstructured":"Ayub M, Basit S, Jelani M, Ur Rehman F, Iqbal M, Yasinzai M, et al. A homozygous nonsense mutation in the human desmocollin-3 (DSC3) gene underlies hereditary hypotrichosis and recurrent skin vesicles. Am J Hum Genet. 2009;85(4):515\u201320.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"967_CR61","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/mus.25701","volume":"57","author":"TD Levine","year":"2018","unstructured":"Levine TD, Bland RJ. Incidence of nonamyloidogenic mutations in the transthyretin gene in patients with autonomic and small fiber neuropathy. Muscle Nerve. 2018;57(1):140\u20132.","journal-title":"Muscle Nerve"},{"issue":"4","key":"967_CR62","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1529-8027.2012.00436.x","volume":"17","author":"M Russo","year":"2012","unstructured":"Russo M, Mazzeo A, Stancanelli C, Di Leo R, Gentile L, Di Bella G, et al. Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. J Peripher Nerv Syst. 2012;17(4):385\u201390.","journal-title":"J Peripher Nerv Syst"},{"issue":"s2","key":"967_CR63","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.3233\/JND-150091","volume":"2","author":"A Mazzeo","year":"2015","unstructured":"Mazzeo A, Russo M, Di Bella G, Minutoli F, Stancanelli C, Gentile L, et al. Transthyretin-related familial amyloid polyneuropathy (TTR-FAP): a single-center experience in Sicily, an Italian endemic area. J Neuromuscul Dis. 2015;2(s2):S39\u201348.","journal-title":"J Neuromuscul Dis"},{"issue":"10","key":"967_CR64","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/ejhf.1285","volume":"20","author":"C Gagliardi","year":"2018","unstructured":"Gagliardi C, Perfetto F, Lorenzini M, Ferlini A, Salvi F, Milandri A, et al. Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure. Eur J Heart Fail. 2018;20(10):1417\u201325.","journal-title":"Eur J Heart Fail"},{"key":"967_CR65","unstructured":"Budowle B, Moretti, T., Smith, J., and Dizinno, J. DNA typing protocols: molecular biology and forensic analysis. A Bio Techniques\u00ae Books Publications (Natick, MA: Eaton Publishing). 2000."},{"issue":"24","key":"967_CR66","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1093\/bioinformatics\/btx513","volume":"33","author":"Y Tian","year":"2017","unstructured":"Tian Y, Morris TJ, Webster AP, Yang Z, Beck S, Feber A, et al. ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics. 2017;33(24):3982\u20134.","journal-title":"Bioinformatics"},{"issue":"1","key":"967_CR67","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118\u201327.","journal-title":"Biostatistics"},{"key":"967_CR68","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2105-13-86","volume":"13","author":"EA Houseman","year":"2012","unstructured":"Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinform. 2012;13:86.","journal-title":"BMC Bioinform."},{"issue":"3","key":"967_CR69","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/gepi.21789","volume":"38","author":"RT Barfield","year":"2014","unstructured":"Barfield RT, Almli LM, Kilaru V, Smith AK, Mercer KB, Duncan R, et al. Accounting for population stratification in DNA methylation studies. Genet Epidemiol. 2014;38(3):231\u201341.","journal-title":"Genet Epidemiol"},{"issue":"5","key":"967_CR70","doi-asserted-by":"publisher","first-page":"e63812","DOI":"10.1371\/journal.pone.0063812","volume":"8","author":"S Zeilinger","year":"2013","unstructured":"Zeilinger S, Kuhnel B, Klopp N, Baurecht H, Kleinschmidt A, Gieger C, et al. Tobacco smoking leads to extensive genome-wide changes in DNA methylation. PLoS ONE. 2013;8(5):e63812.","journal-title":"PLoS ONE"},{"issue":"13","key":"967_CR71","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.2217\/epi-2019-0206","volume":"11","author":"S Bollepalli","year":"2019","unstructured":"Bollepalli S, Korhonen T, Kaprio J, Anders S, Ollikainen M. EpiSmokEr: a robust classifier to determine smoking status from DNA methylation data. Epigenomics. 2019;11(13):1469\u201386.","journal-title":"Epigenomics"},{"key":"967_CR72","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol). 1995;57:289\u2013300.","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"967_CR73","doi-asserted-by":"crossref","unstructured":"Wickham H. ggplot2: Elegant graphics for data analysis. Springer, New York. 2016.","DOI":"10.1007\/978-3-319-24277-4"},{"issue":"D1","key":"967_CR74","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"key":"967_CR75","doi-asserted-by":"crossref","unstructured":"The Gene Ontology C. The gene ontology resource: 20 years and still GOing strong. Nucleic Acids Res. 2019;47(D1):D330-D8.","DOI":"10.1093\/nar\/gky1055"},{"issue":"D1","key":"967_CR76","first-page":"D498","volume":"48","author":"B Jassal","year":"2020","unstructured":"Jassal B, Matthews L, Viteri G, Gong C, Lorente P, Fabregat A, et al. The reactome pathway knowledgebase. Nucleic Acids Res. 2020;48(D1):D498\u2013503.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"967_CR77","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353\u201361.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"967_CR78","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12859-019-2804-7","volume":"20","author":"S Graw","year":"2019","unstructured":"Graw S, Henn R, Thompson JA, Koestler DC. pwrEWAS: a user-friendly tool for comprehensive power estimation for epigenome wide association studies (EWAS). BMC Bioinform. 2019;20(1):218.","journal-title":"BMC Bioinform."}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00967-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13148-020-00967-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00967-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T11:19:41Z","timestamp":1723893581000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-020-00967-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["967"],"URL":"https:\/\/doi.org\/10.1186\/s13148-020-00967-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.13.20064006","asserted-by":"object"}]},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"assertion":[{"value":"7 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved under the protocol 39\/18 by the Comitato Etico Indipendente, Fondazione Policlinico Tor Vergata\u2014Rome, Italy. Informed consent was obtained from each participant involved.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Drs. Fuciarelli and Polimanti received research grants from Pfizer Inc. to conduct epigenetic studies of hATTR. The other authors reported no biomedical financial interests or potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}